Randal D. Chase, Director at BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), bought 15,000 shares at $1.35 ($20K) on 2006-06-07, disclosed to the SEC on 2006-06-07.
Open-market purchase of $20k BJCT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| GOVX | BUY | 2020-09-29 | $83K | — | Filing → |
| GOVX | BUY | 2015-05-05 | $2K | — | Filing → |
| GOVX | BUY | 2015-04-20 | $5K | — | Filing → |